Mark Stephenson, CEO of Reframe Cancer, highlights why employers and insurers must prioritise early cancer detection and screening to save lives, cut costs, and support a healthier...

Younger employees are becoming the fastest-growing cancer risk group, yet most remain unaware of how their everyday choices affect their health, according to a new report from Perci...

Cancer patients in the UK are facing nearly £10,000 a year in hidden costs linked to their diagnosis, new research from insurer Zurich UK has revealed.

Returning to work is the top ‘practical’ concern (83%) for employees with cancer, a partnership between L&G and Perci Health has shown - significantly ahead of concerns...

A significant percentage of women who were recently surveyed by Aviva mistakenly believed that ovarian cancer could be diagnosed through a smear test.

Ahead of World Cancer Day (4th February), RedArc has revealed it received 33% more new cancer cases than the next most supported condition, mental health, between 2020-24.

According to the latest research commissioned by Aviva, just under one in five (18%) women said they don’t know what to look for when checking their breasts.

Today, the Office for National Statistics (ONS) released new data on waiting times for cancer treatment across the UK which Brett Hill, Head of Health & Protection at Broadstone,...

Rokstone, part of the Aventum Group, has launched a new cancer scheme in partnership with Pulse & Reframe Cancer, which goes beyond traditional critical illness & cancer...

According to the latest research commissioned by Reframe Cancer, 66% of employees don’t think their employer was quick to respond and offer support upon receiving a cancer...